Palantir Technologies has issued additional details about the Palantir Foundry capabilities, reports Businesswire. The details will be highlighted in the company’s Life Sciences demo at “Double Click” on Wednesday, April 14, 2021, at 11:00am ET.
Engineers will also demonstrate several new Archetypes available that make work possible in a matter of clicks.
Palantir’s Life Sciences customers range from pharmaceuticals, research institutions, healthcare systems, and others
The customers rely on Foundry’s secure and collaborative architecture to discover and develop drugs, manage commercial launches, conduct clinical research, and distribute vaccines. Palantir stock is currently declining. PLTR: NYSE is down 0.52% on premarket.
